LSD1-IN-32
LSD1-IN-32 (compound 11e) is a potent LSD1 inhibitor with an IC50 value of 0.99 µM. LSD1-IN-32 inhibits RANKL-induced osteoclastogenesis, bone resorption and F-actin belt formation. LSD1-IN-32 has the potential for the research of osteoporosis.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C36H56N2O3Si2
- Molecular Weight:621.01
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Histone Methyltransferase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
IC50: 0.99 µM (LSD1)[1]
In Vitro
LSD1-IN-32 (compound 11e) (1.25, 2.5, 5 µM) increases the methylation level during osteoclastogenesis in a dose-dependent manner[1].
LSD1-IN-32 (0.25, 0.5, 1, 2, 4 µM) inhibits RANKL-induced osteoclastogenesis, bone resorption and F-actin belt formation[1].
LSD1-IN-32 (2 µM; 0, 1, 2, 4 days) reduces the relative mRNA expression levels induced by RANKL of those genes of Acp5, Nfatc1, Oscar, Dc-stamp, Atp6v0d2, and Ctsk[1].
LSD1-IN-32 (0.5, 1, 2, 4 µM) inhibits the expressions of p-LSD1, p-IκB and p-NFκB in RANKL-induced osteoclastogenesis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:osteoclasts
-
Concentration:2 µM
-
Incubation Time:0, 1, 2, 4 days
-
Result:Reduced the relative mRNA expression levels of those genes (Acp5, Nfatc1, Oscar, Dc-stamp, Atp6v0d2, and Ctsk) induced by RANKL.
-
Cell Line:osteoclasts
-
Concentration:0.5, 1, 2, 4 µM
-
Incubation Time:
-
Result:Dose dependently inhibited the expressions of p-LSD1, p-IκB and p-NFκB in RANKL-induced osteoclastogenesis.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:7-week-old C57BL/6 female mice (OVX (ovariectomy)-induced osteoporosis)[1]
-
Dosage:5, 10 mg/kg
-
Administration:I.p.; daily for four weeks
-
Result:Significantly reduced the loss of the bone mass, reduced OVX-induced osteoclastic bone loss.
Chemical Information
-
Molecular Weight 621.01
-
Formel C36H56N2O3Si2
-
SMILES
O=C(N1CCC(CN[C@H]2[C@H](C3=CC=CC=C3)C2)CC1)/C=C/C4=CC=C(O[Si](C)(C(C)(C)C)C)C(O[Si](C)(C(C)(C)C)C)=C4
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Osteoclast differentiation from monocyte/macrophage precursors
Osteoclast differentiation is an in vitro induction assay in which monocyte/macrophage-lineage precursors are exposed to macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-κB ligand (RANKL), generating multinucleated osteoclasts that are commonly identified by tartrate-resistant acid phosphatase (TRAP) staining and functionally confirmed by resorption pits on dentin, bone, or mineralized substrates. M-CSF supports survival and expansion of osteoclast precursors, while RANKL binding to RANK drives osteoclast commitment, fusion, maturation, and resorptive function; osteoprotegerin inhibits this pathway by binding RANKL and preventing RANK activation. The main readouts are the number of TRAP-positive multinucleated cells, formation of F-actin rings, and resorbed surface area; TRAP-positive multinucleated cells indicate osteoclast differentiation, whereas pit formation on dentin, bone, or mineralized coating indicates functional bone-resorbing activity.
-
Phalloidin F-actin cytoskeleton staining
Phalloidin F-actin staining detects polymerized filamentous actin in fixed and permeabilized specimens by using fluorescent phalloidin or phalloidin-derived phallotoxins that bind actin filaments and generate a fluorescence microscopy readout corresponding to F-actin organization, including stress fibers, cortical actin, filament bundles, and tissue-specific actin networks. Phalloidin stabilizes F-actin by reducing actin subunit dissociation from filament ends, and fluorescent phallotoxins were established as tools for visualizing actin-containing structures in eukaryotic cells.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)